Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
In the last decades, the global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached pandemic proportions with derived major health and socioeconomic consequences; this tendency is expected to be further aggravated in the coming years. Obesity, insulin resistance/type 2 diabetes melli...
Guardado en:
Autores principales: | José Ignacio Martínez-Montoro, Isabel Cornejo-Pareja, Ana María Gómez-Pérez, Francisco J. Tinahones |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/21c12234cddf4052bd76037c1ed66109 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study
por: Tracy Bonsu Osei, et al.
Publicado: (2021) -
APOE ɛ4 Is Associated with Postprandial Inflammation in Older Adults with Metabolic Syndrome Traits
por: Yannik Bernd Schönknecht, et al.
Publicado: (2021) -
Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar R, et al.
Publicado: (2018) -
NADH and NRH as potential dietary supplements or pharmacological agents for early liver injury caused by acute alcohol exposure
por: Ke Wu, et al.
Publicado: (2021) -
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Kaitlin Day, et al.
Publicado: (2021)